Machine-assisted Chinese translation is in progress. This page is shown in English pending professional review.

Quality & Regulatory

Six documented accreditations, one manufacturing site.

Every accreditation on this register is issued and renewed independently by its own regulator, against Mac-Chem's manufacturing facility at MIDC Tarapur, Boisar, Maharashtra, not against any single product.

6 documented accreditations · India GMP · WHO-GMP · EDQM CEP · Swissmedic · CDSCO Written Confirmation · ISO 14001 / 45001

Accreditation register

Six accreditations, confirmed from certificates on file

Mac-Chem's Boisar facility holds six documented manufacturing accreditations, each confirmed from the issued certificate held on file: an India GMP certificate from the Maharashtra FDA, WHO-GMP certification, an EDQM Certificate of Suitability (CEP), a Swissmedic GMP compliance certificate, a CDSCO Written Confirmation for EU API export, and ISO 14001 / ISO 45001 certification for environmental and occupational health-and-safety management. Each carries issuing body, scope, site, and validity where the certificate states it.

Pending approval Further national approvals are on record and being digitized for publication with the same level of certificate detail.

Market access

Each accreditation is a key to a specific market

Regulatory affairs teams read this register as a market-access map, not a trophy wall. The six accreditations group into three tracks: EU and regulated export, WHO-regulated / rest-of-world export, and domestic supply.

Each certificate is scoped to the Boisar site's quality systems and process controls. It does not itself constitute approval of any individual product, and every underlying product registration still depends on its own dossier being filed and maintained in that market.

Certificate detail

What each certificate covers

The India GMP certificate (Maharashtra FDA, certificate 6134110) covers Bulk Drugs / API manufacturing under Forms 25 (KD/715) and 28 (KD/506), valid through May 2029. WHO-GMP certification covers 109 approved products across lyophilized/powder injectable and cytotoxic and general APIs, valid through January 2028. The EDQM CEP (2012-025, Suxamethonium Chloride) followed an EDQM inspection in October 2023 with attestation in March 2024. The Swissmedic GMP compliance certificate (CH23-0006, Suxamethonium Chloride) followed the same October 2023 inspection and was issued in February 2024. The CDSCO Written Confirmation (WC-0275) covers 35 APIs exported to the EU and is valid for three years from May 2024. ISO 14001:2015 and ISO 45001:2018 (Bureau Veritas, certificate IND.24.2007/IM/U) were issued in December 2024, valid through December 2027.

Product quality

Quality and dossier queries

Formulation manufacturers, distributors, and regulatory affairs contacts can raise a certificate, batch, or dossier query through the Contact page. Each query is logged and routed to the regulatory affairs contact responsible for the market in question. Mac-Chem does not make, and this page does not imply, any claim about the safety or efficacy of a finished drug product; certification and query-handling statements here describe manufacturing quality systems and process controls only.

Pending approval A named quality-management-system framework and formal SOP references are pending company confirmation and are not published here until verified.